82 FR 132 pg. 32169 - Foreign-Trade Zone (FTZ) 7—Mayaguez, Puerto Rico; Authorization of Production Activity; Bristol-Myers Squibb Holdings Pharma, Ltd. (Pharmaceuticals); Manati, Puerto Rico
Type: NOTICEVolume: 82Number: 132Page: 32169
Page: 32169Docket number: [B-16-2017]
FR document: [FR Doc. 2017-14612 Filed 7-11-17; 8:45 am]
Agency: Commerce Department
Sub Agency: Foreign-Trade Zones Board
Official PDF Version: PDF Version
[top]
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
[B-16-2017]
Foreign-Trade Zone (FTZ) 7-Mayaguez, Puerto Rico; Authorization of Production Activity; Bristol-Myers Squibb Holdings Pharma, Ltd. (Pharmaceuticals); Manati, Puerto Rico
On March 6, 2017, Bristol-Myers Squibb Holdings Pharma, Ltd. submitted a notification of proposed production activity to the FTZ Board within Subzone 7J, in Manati, Puerto Rico.
The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (82 FR 13578, March 14, 2017). On July 5, 2017, the applicant was notified of the FTZ Board's decision that no further review of the activity is warranted at this time. The production activity described in the notification was authorized, subject to the FTZ Act and the FTZ Board's regulations, including Section 400.14.
Dated: July 7, 2017.
Elizabeth Whiteman,
Acting Executive Secretary.
[FR Doc. 2017-14612 Filed 7-11-17; 8:45 am]
BILLING CODE 3510-DS-P